Want to see PHAT full AI Analyst Report?
Phathom Pharmaceuticals (PHAT) Ownership Overview
8.89% Insiders
13.06% Mutual Funds
48.90% Other Institutional Investors
9.31% ETFs
19.84% Public Companies and
Individual Investors
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 71.26% of the company’s stock is owned by Institutional Investors, 8.89% is owned by Insiders, and 19.84% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 05, 2025 | xxxxxxxxxxxxx | $7079 | |
Sep 09, 2025 | xxxxxxxxxxxxx | $5573 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $956254 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $5772200 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,957,449 | Insider | 7.36% | 53,914,913 | |
| 3,070,919 | Institution | 3.80% | 27,791,817 | |
| 2,797,871 | Institution | 3.46% | 25,320,733 | |
| 2,520,470 | Institution | 3.12% | 22,810,254 | |
| 1,301,277 | Institution | 1.61% | 11,776,557 | |
| 1,052,910 | Institution | 1.30% | 9,528,836 | |
| 819,324 | Institution | 1.01% | 7,414,882 | |
| 790,794 | Institution | 0.98% | 7,156,686 | |
| 746,710 | Institution | 0.92% | 6,757,726 | |
| 636,772 | Institution | 0.79% | 5,762,787 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,520,470 | Institution | 3.12% | 22,810,254 | |
| 1,301,277 | Institution | 1.61% | 11,776,557 | |
| 1,052,910 | Institution | 1.30% | 9,528,836 | |
| 819,324 | Institution | 1.01% | 7,414,882 | |
| 746,710 | Institution | 0.92% | 6,757,726 | |
| 636,772 | Institution | 0.79% | 5,762,787 | |
| 476,736 | Institution | 0.59% | 4,314,461 | |
| 464,839 | Institution | 0.57% | 4,206,793 | |
| 312,631 | Institution | 0.39% | 2,829,311 | |
| 264,096 | Institution | 0.33% | 2,390,069 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,007,668 | Institution | 2.48% | 17,567,095 | |
| 1,259,135 | Institution | 1.56% | 11,395,172 | |
| 587,673 | Institution | 0.73% | 5,142,139 | |
| 568,557 | Institution | 0.70% | 5,264,838 | |
| 423,673 | Institution | 0.52% | 3,834,241 | |
| 329,174 | Institution | 0.41% | 2,979,025 | |
| 275,981 | Institution | 0.34% | 2,414,834 | |
| 249,267 | Institution | 0.31% | 2,255,866 | |
| 244,892 | Institution | 0.30% | 2,267,700 | |
| 185,044 | Institution | 0.23% | 1,674,648 |
FAQ
Who Owns Phathom Pharmaceuticals (PHAT)?
According to the latest TipRanks data, approximately 48.90% of the company's stock is held by institutional investors, 8.89% is held by insiders, and 19.84% is held by retail investors.
What percentage of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 48.90% of Phathom Pharmaceuticals (PHAT) stock is held by institutional investors.
What percentage of Phathom Pharmaceuticals (PHAT) stock is held by retail investors?
According to the latest TipRanks data, approximately 19.84% of Phathom Pharmaceuticals (PHAT) stock is held by retail investors.
Who owns the most shares of Phathom Pharmaceuticals (PHAT)?
James Topper owns the most shares of Phathom Pharmaceuticals (PHAT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.